logo
Select company
Select metric
18.42%Cash Return on Invested Capital
VS
Market
90
Sector
95
Industry
96
History
100
$ 5.33Close
$ 1.36 - $ 5.68 52-Week Range
Ticker Information

Ticker

NEPH

Company Name

NEPHROS INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

NEPHROS INC - Cash Return on Invested Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NEPH - CROIC Historical data
DateCash Return on Invested CapitalFree Cash FlowInvested Capital
6/30/202518.42%$ 2M$ 10.84M
3/31/20254.73%$ 502K$ 10.62M
12/31/2024-5.42%$ -542K$ 10M
9/30/2024-21.81%$ -2.11M$ 9.67M
6/30/2024-9.71%$ -923K$ 9.51M
3/31/2024-1.98%$ -196K$ 9.89M
12/31/20237.38%$ 752K$ 10.19M
9/30/20239.24%$ 869K$ 9.4M
6/30/20231.44%$ 137K$ 9.51M
3/31/2023-12.87%$ -1.26M$ 9.82M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NEPHROS INC's latest trailing twelve months (TTM) CROIC stands at -49.08%.
  • Over the past 5 years, NEPHROS INC's average CROIC has been -18.83%.
  • The median CROIC for NEPHROS INC during this period was -16.19%
  • NEPHROS INC reached its highest CROIC over the past 5 years at 18.42%.
  • The lowest CROIC recorded by NEPHROS INC in the same timeframe -51.07%

NEPHROS INC's CROIC vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CROIC Benchmarks
CompanyCROIC
POCI : PRECISION OPTICS CORPORATION INC -26.4%NXGL : NEXGEL INC -40.73%EKSO : EKSO BIONICS HOLDINGS INC -56.36%VVOS : VIVOS THERAPEUTICS INC -96.93%XLO : XILIO THERAPEUTICS INC -94.06%FEMY : FEMASYS INC -218.08%MLSS : MILESTONE SCIENTIFIC INC -118.98%GBIO : GENERATION BIO CO -58.36%PRPO : PRECIPIO INC 3.79%BNGO : BIONANO GENOMICS INC -40.13%

Definition of Cash Return on Invested Capital

[Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].
FCF / Inv. Capital
(=) CROIC
CROIC for NEPHROS INC is calculated as follows: FCF [ $ -5.25M ] / Inv. Capital [ $ 10.7M ]
(=) CROIC [ -49.08% ]

NEPH - Cash Return on Invested Capital, Last 5 years

-51.07%

Minimum

Sep 30, 2022

18.42%

Maximum

Jun 30, 2025

-18.83%

Average

-16.19%

Median

CROIC Benchmark Analysis

The chart above depicts the distribution of CROIC for companies in the Total Stock Market. The average CROIC of the companies is 2.8% with a standard deviation of 15%.
The following table provides additional summary stats:
CROIC in the Market:
filtered constituents3.46K
min-43.7%
max49.3%
average2.8%
median4.99%
std15%